UniProt ID | MTA3_HUMAN | |
---|---|---|
UniProt AC | Q9BTC8 | |
Protein Name | Metastasis-associated protein MTA3 | |
Gene Name | MTA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 594 | |
Subcellular Localization | Nucleus . | |
Protein Description | Plays a role in maintenance of the normal epithelial architecture through the repression of SNAI1 transcription in a histone deacetylase-dependent manner, and thus the regulation of E-cadherin levels. Contributes to transcriptional repression by BCL6.. | |
Protein Sequence | MAANMYRVGDYVYFENSSSNPYLIRRIEELNKTASGNVEAKVVCFYRRRDISNTLIMLADKHAKEIEEESETTVEADLTDKQKHQLKHRELFLSRQYESLPATHIRGKCSVALLNETESVLSYLDKEDTFFYSLVYDPSLKTLLADKGEIRVGPRYQADIPEMLLEGESDEREQSKLEVKVWDPNSPLTDRQIDQFLVVARAVGTFARALDCSSSVRQPSLHMSAAAASRDITLFHAMDTLYRHSYDLSSAISVLVPLGGPVLCRDEMEEWSASEASLFEEALEKYGKDFNDIRQDFLPWKSLTSIIEYYYMWKTTDRYVQQKRLKAAEAESKLKQVYIPTYSKPNPNQISTSNGKPGAVNGAVGTTFQPQNPLLGRACESCYATQSHQWYSWGPPNMQCRLCAICWLYWKKYGGLKMPTQSEEEKLSPSPTTEDPRVRSHVSRQAMQGMPVRNTGSPKSAVKTRQAFFLHTTYFTKFARQVCKNTLRLRQAARRPFVAINYAAIRAEYADRHAELSGSPLKSKSTRKPLACIIGYLEIHPAKKPNVIRSTPSLQTPTTKRMLTTPNHTSLSILGKRNYSHHNGLDELTCCVSD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | NMYRVGDYVYFENSS CCEEECCEEEEECCC | 7.36 | 22817900 | |
13 | Phosphorylation | YRVGDYVYFENSSSN EEECCEEEEECCCCC | 10.03 | - | |
16 | Phosphorylation | GDYVYFENSSSNPYL CCEEEEECCCCCCHH | 36.97 | - | |
17 | Phosphorylation | DYVYFENSSSNPYLI CEEEEECCCCCCHHH | 28.13 | - | |
32 | Acetylation | RRIEELNKTASGNVE HHHHHHHCCCCCCCE | 59.08 | 26051181 | |
32 (in isoform 2) | Ubiquitination | - | 59.08 | - | |
33 | Phosphorylation | RIEELNKTASGNVEA HHHHHHCCCCCCCEE | 25.61 | - | |
35 | Phosphorylation | EELNKTASGNVEAKV HHHHCCCCCCCEEEE | 35.81 | 28348404 | |
41 | Acetylation | ASGNVEAKVVCFYRR CCCCCEEEEEEEEEE | 22.99 | 26051181 | |
46 | Phosphorylation | EAKVVCFYRRRDISN EEEEEEEEEECCCHH | 9.70 | - | |
52 | Phosphorylation | FYRRRDISNTLIMLA EEEECCCHHHHHHHH | 28.22 | 20068231 | |
54 | Phosphorylation | RRRDISNTLIMLADK EECCCHHHHHHHHHH | 15.75 | 20068231 | |
57 | Sulfoxidation | DISNTLIMLADKHAK CCHHHHHHHHHHHHH | 2.58 | 21406390 | |
61 (in isoform 2) | Ubiquitination | - | 39.59 | 21890473 | |
61 (in isoform 1) | Ubiquitination | - | 39.59 | 21890473 | |
61 | Ubiquitination | TLIMLADKHAKEIEE HHHHHHHHHHHHHHH | 39.59 | 21890473 | |
72 | Phosphorylation | EIEEESETTVEADLT HHHHHCCCEEEECCC | 45.48 | - | |
73 | Phosphorylation | IEEESETTVEADLTD HHHHCCCEEEECCCH | 16.58 | - | |
91 | Ubiquitination | HQLKHRELFLSRQYE HHHHHHHHHHHHCHH | 5.44 | - | |
129 | Phosphorylation | SYLDKEDTFFYSLVY HHCCCCCCCEEEEEE | 19.41 | 28787133 | |
130 | Phosphorylation | YLDKEDTFFYSLVYD HCCCCCCCEEEEEEC | 9.29 | - | |
133 | Phosphorylation | KEDTFFYSLVYDPSL CCCCCEEEEEECCCH | 13.25 | 28787133 | |
161 | Methylation | PRYQADIPEMLLEGE CCCCCCCCHHHHCCC | 22.84 | - | |
186 | Phosphorylation | VKVWDPNSPLTDRQI EEEECCCCCCCHHHH | 27.03 | - | |
213 | Phosphorylation | FARALDCSSSVRQPS HHHHHCCCCCCCCCC | 25.89 | 23879269 | |
214 | Phosphorylation | ARALDCSSSVRQPSL HHHHCCCCCCCCCCH | 38.90 | 23879269 | |
215 | Phosphorylation | RALDCSSSVRQPSLH HHHCCCCCCCCCCHH | 12.67 | 23879269 | |
217 | Methylation | LDCSSSVRQPSLHMS HCCCCCCCCCCHHHH | 44.64 | - | |
220 | Phosphorylation | SSSVRQPSLHMSAAA CCCCCCCCHHHHHHH | 23.67 | 21406692 | |
224 | Phosphorylation | RQPSLHMSAAAASRD CCCCHHHHHHHHHCC | 12.19 | 21406692 | |
229 | Phosphorylation | HMSAAAASRDITLFH HHHHHHHHCCHHHHH | 26.26 | 21406692 | |
232 | Ubiquitination | AAAASRDITLFHAMD HHHHHCCHHHHHHHH | 3.33 | - | |
233 | Phosphorylation | AAASRDITLFHAMDT HHHHCCHHHHHHHHH | 27.88 | 25867546 | |
240 | Phosphorylation | TLFHAMDTLYRHSYD HHHHHHHHHHHHCCC | 16.77 | 25867546 | |
242 | Phosphorylation | FHAMDTLYRHSYDLS HHHHHHHHHHCCCHH | 14.36 | 25867546 | |
267 | Ubiquitination | GPVLCRDEMEEWSAS CCEECCHHHHHCCHH | 29.19 | - | |
272 | Phosphorylation | RDEMEEWSASEASLF CHHHHHCCHHHHHHH | 25.79 | 29759185 | |
302 | Phosphorylation | QDFLPWKSLTSIIEY HHCCCHHHHHHHHHH | 32.77 | 24043423 | |
304 | Phosphorylation | FLPWKSLTSIIEYYY CCCHHHHHHHHHHHH | 25.60 | 24043423 | |
305 | Phosphorylation | LPWKSLTSIIEYYYM CCHHHHHHHHHHHHH | 27.19 | 24043423 | |
309 | Phosphorylation | SLTSIIEYYYMWKTT HHHHHHHHHHHHHHH | 6.89 | 24043423 | |
310 | Phosphorylation | LTSIIEYYYMWKTTD HHHHHHHHHHHHHHH | 3.66 | 24043423 | |
311 | Phosphorylation | TSIIEYYYMWKTTDR HHHHHHHHHHHHHHH | 8.80 | 24043423 | |
356 | Acetylation | QISTSNGKPGAVNGA CCCCCCCCCCCCCCC | 44.52 | 26051181 | |
365 | Phosphorylation | GAVNGAVGTTFQPQN CCCCCCCCCCCCCCC | 20.64 | - | |
369 | Ubiquitination | GAVGTTFQPQNPLLG CCCCCCCCCCCCCCC | 36.26 | - | |
371 | Phosphorylation | VGTTFQPQNPLLGRA CCCCCCCCCCCCCHH | 54.08 | 20068231 | |
373 | Phosphorylation | TTFQPQNPLLGRACE CCCCCCCCCCCHHCC | 24.58 | 18452278 | |
375 | Phosphorylation | FQPQNPLLGRACESC CCCCCCCCCHHCCCC | 4.62 | - | |
376 | Phosphorylation | QPQNPLLGRACESCY CCCCCCCCHHCCCCC | 23.87 | 20068231 | |
398 | Phosphorylation | YSWGPPNMQCRLCAI CCCCCCCHHHHHHHH | 4.99 | - | |
400 | Phosphorylation | WGPPNMQCRLCAICW CCCCCHHHHHHHHHH | 2.20 | - | |
413 | Phosphorylation | CWLYWKKYGGLKMPT HHHHHHHHCCCCCCC | 16.82 | 29083192 | |
420 | Phosphorylation | YGGLKMPTQSEEEKL HCCCCCCCCCCCCCC | 41.03 | 29255136 | |
422 | Phosphorylation | GLKMPTQSEEEKLSP CCCCCCCCCCCCCCC | 49.83 | 29255136 | |
426 | Acetylation | PTQSEEEKLSPSPTT CCCCCCCCCCCCCCC | 58.50 | 26051181 | |
426 (in isoform 2) | Ubiquitination | - | 58.50 | - | |
428 | Phosphorylation | QSEEEKLSPSPTTED CCCCCCCCCCCCCCC | 34.11 | 29255136 | |
430 | Phosphorylation | EEEKLSPSPTTEDPR CCCCCCCCCCCCCHH | 31.35 | 30266825 | |
432 | Phosphorylation | EKLSPSPTTEDPRVR CCCCCCCCCCCHHHH | 47.34 | 30266825 | |
433 | Phosphorylation | KLSPSPTTEDPRVRS CCCCCCCCCCHHHHH | 41.60 | 30266825 | |
455 | Phosphorylation | QGMPVRNTGSPKSAV CCCCCCCCCCCHHHH | 28.59 | 22199227 | |
457 | Phosphorylation | MPVRNTGSPKSAVKT CCCCCCCCCHHHHHH | 27.41 | 22199227 | |
460 | Phosphorylation | RNTGSPKSAVKTRQA CCCCCCHHHHHHHHH | 41.50 | - | |
462 | Phosphorylation | TGSPKSAVKTRQAFF CCCCHHHHHHHHHHH | 9.32 | 32645325 | |
464 | Phosphorylation | SPKSAVKTRQAFFLH CCHHHHHHHHHHHHH | 22.78 | 22210691 | |
496 | Phosphorylation | LRQAARRPFVAINYA HHHHHHCCEEEEEHH | 23.63 | - | |
502 (in isoform 2) | Phosphorylation | - | 7.41 | - | |
508 | Phosphorylation | NYAAIRAEYADRHAE EHHHHHHHHHHHHHH | 31.26 | - | |
510 (in isoform 2) | Ubiquitination | - | 10.00 | - | |
517 | Phosphorylation | ADRHAELSGSPLKSK HHHHHHHCCCCCCCC | 28.82 | 30266825 | |
519 | Phosphorylation | RHAELSGSPLKSKST HHHHHCCCCCCCCCC | 24.55 | 23401153 | |
523 | Phosphorylation | LSGSPLKSKSTRKPL HCCCCCCCCCCCCCC | 39.25 | 23312004 | |
536 | Phosphorylation | PLACIIGYLEIHPAK CCEEEEEEEEECCCC | 7.25 | - | |
553 | Phosphorylation | NVIRSTPSLQTPTTK CCCCCCCCCCCCCCC | 32.95 | 29396449 | |
556 | Phosphorylation | RSTPSLQTPTTKRML CCCCCCCCCCCCCCC | 28.09 | 28674419 | |
558 | Phosphorylation | TPSLQTPTTKRMLTT CCCCCCCCCCCCCCC | 48.62 | 29396449 | |
559 | Phosphorylation | PSLQTPTTKRMLTTP CCCCCCCCCCCCCCC | 20.18 | 29396449 | |
565 | Phosphorylation | TTKRMLTTPNHTSLS CCCCCCCCCCCCCCC | 20.38 | - | |
589 | Phosphorylation | HNGLDELTCCVSD-- CCCCCEEEEEECC-- | 11.21 | 23663014 | |
593 | Phosphorylation | DELTCCVSD------ CEEEEEECC------ | 24.56 | 23663014 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTA3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTA3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTA3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...